Alterations in lipid profile of autistic boys: A case control study

Nutrition Research

Volumn 30, Issue 4, 2010, Pages 255-260

  Kim, Eun Kyung ^a   Neggers, Yasmin H ^b   Shin, Cheung Soo ^c   Kim, Eunkyeong ^a   Kim, Eun Mi ^d  

^a Gangneung Wonju National University   (South Korea)

^b THE UNIVERSITY OF ALABAMA   (United States)

^c Yonsei University College of Medicine   (South Korea)

^d Eunpheong Daeyoung School   (South Korea)

Author keywords

Autism; Boys; HDL; LDL; LDL HDL ratio; Lipids

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; FOOD INTAKE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

AUTISTIC DISORDER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; HUMANS; LIPIDS; MALE; REGRESSION ANALYSIS; REPUBLIC OF KOREA; TRIGLYCERIDES;

EID: 77953337740     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2010.04.002     Document Type: Article

References (23)

1. Aneja A., Tierney E. Autism: the role of cholesterol in treatment. Intl Rev. Psychiatry 2008, 20:165-170.
2. Meiri G., Bichovsky Y., Belmaker R.H. Omega-3 fatty acid treatment in autism. J Child Adolesc Psycopharmacol 2009, 19:449-451.
3. Curtis L.T., Patel K. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder: a review. J Altern Complement Med 2008, 4:79-85.
4. Grether J.K., Anderson M.C., Croen L.A., Smith D., Windham G.C. Risk of autism and increasing maternal and paternal age in a large North American population. Am J Epidemiol 2009, 170:118-126.
5. Assessment, diagnosis and clinical interventions for children and young people with spectrum disorders. Scottish Intercollegiate Guidelines Network. 2007. Edinburgh EH2 1EN pp. 1-87.
6. Dawson S., Glasson E.J., Dixon G., Bower C. Birth defects in children with autism spectrum disorders: a population-based nested case-control study. Am J Epidemiol 2009, 169:296-1303.
7. Prevalence of Autism Spectrum Disorders-Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 2009, 58(ss10):1-20.
8. Ministry of Education and Human Resources Development Annual report of Special Education in South Korea 2007, Korean Government Publication.
9. Wiest M.M., German J.B., Harvey D.J., Watkins S.M., Hertz-Picciotto I. Plasma fatty acid profiles in autism: a case control study. Prostag Leukot Essen Fatty Acids 2009, 10.1016/j.plefa.2009.01.007.
10. Korean Center for Disease Control and Prevention Risk factor analysis of childhood obesity and abnormal metabolic diseases. 2nd Report 2006, Korean Government Publication.
11. Report of Expert Panel on Blood Cholesterol Levels in Children and Adolescents. (1991). U.S. Department of Health and Human Services, National Institutes of Health. National Heart, Lung, and Blood Institute. National Cholesterol Education Program. NIH Publication No. 91-2732.
12. Huang Y.-C., Ho C.-C., Lin P.-T., Lee B.-J., La H.-L., Liaw Y.-P. Optimal cutoff value of high-density lipoprotein cholesterol for predicting coronary artery disease in Taiwanese population. Nutr Res 2010, 30:21-26.
13. Dziobeck I., Gold S.M., Wolf O.T., Convit A. Hypercholesterolemia in Asperger syndrome: independence from lifestyle, obsessive-compulsive behavior, and social anxiety. Psychiatr Res 2007, 149:321-324.
14. Landien M., Baghael F., Rosmond R., Goran H., Bjorntrop P., Eriksso E. Dyslipidemia and high waist-hip ratio in women with self-reported social anxiety. Psychoneuroendocrinology 2004, 29:1037-1046.
15. Monteleone P., Santonastaso P., Pannuto M., Favaro A., Caregaro L., Castaldo E., et al. Enhanced serum cholesterol and triglycerides levels in bulimia nervosa: relationships to psychiatric co-morbidity, psychopathology and hormonal variables. Psychiatr Res 2005, 34:267-273.
16. Peter H., Hand I., Hohagen F., Koenig A., Mindermann O., Oeder F., et al. Serum cholesterol level comparison: control subjects, anxiety disorder patients, and obsessive-compulsive disorder patients. Can J Psych 2002, 47:557-561.
17. Tierney E., Bukelis I., Thomson R.E., Ahmed K., Aneja A., Kratz L., et al. Abnormalities of cholesterol metabolism in autism spectrum disorders. Am J Med Genet Neuropsychiatry Genet 2006, 14:666-668.
18. American Psychiatric Association Diagnostic and Statistical Manual for Mental Disorders, 3rd revision, DSM III-R 1987, American Psychiatric Press, Washington, DC.
19. Kim E.-K., Kim E.-K., Kim E.-Mi. Comparison of nutrient intakes between disabled children (mental retardation, autism and cerebral palsy) and non-disabled children. Korean J Comm Nutr 2004, 9:121-134.
20. Sevincok L., Buyukozturk A., Dereboy F. Serum lipid concentrations in patients with comorbid generalized anxiety disorder and major depressive disorder. Can J Psychiatry 2001, 46:68-71.
21. Tiao-Lai H., Shu-Chuan W., Yu-Shao C., Jung-Fu C. Correlation between serum lipid, lipoprotein concentration and anxious state or major depressive disorder. Psychiatr Res 2003, 118:147-153.
22. Noori M., Darabi M., Rahimipour A., Rahbani M., Abadi N.A., Darabi M., et al. Fatty acid composition of HDL phospholipids and coronary artery disease. J Clin Lipidol 2009, 3:39-44.
23. Neggers Y.H., Kim E.K., Song J.M., Chung E.J., Um Y.S., Park T. Mental retardation is associated with plasma omega-3 fatty acid levels and the omega-3/omega-6 ratio in children. Asia Pac J Nutr 2009, 18:22-28.